ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 98 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2021. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,227 | -0.9% | 21,753 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $15,358 | -53.5% | 21,753 | 0.0% | 0.00% | -60.0% |
Q3 2022 | $33,000 | +50.0% | 21,753 | 0.0% | 0.01% | +66.7% |
Q2 2022 | $22,000 | -29.0% | 21,753 | 0.0% | 0.00% | -25.0% |
Q1 2022 | $31,000 | -72.8% | 21,753 | 0.0% | 0.00% | -75.0% |
Q4 2021 | $114,000 | -10.2% | 21,753 | 0.0% | 0.02% | -20.0% |
Q3 2021 | $127,000 | -27.4% | 21,753 | 0.0% | 0.02% | -28.6% |
Q2 2021 | $175,000 | -3.3% | 21,753 | 0.0% | 0.03% | -6.7% |
Q1 2021 | $181,000 | +9.0% | 21,753 | -0.9% | 0.03% | -23.1% |
Q4 2020 | $166,000 | -29.1% | 21,948 | 0.0% | 0.04% | -45.8% |
Q3 2020 | $234,000 | -29.7% | 21,948 | 0.0% | 0.07% | -29.4% |
Q2 2020 | $333,000 | +82.0% | 21,948 | 0.0% | 0.10% | +43.7% |
Q1 2020 | $183,000 | -51.7% | 21,948 | -2.2% | 0.07% | -50.0% |
Q4 2019 | $379,000 | – | 22,448 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
Miura Global Management | 435,000 | $8,348,000 | 0.63% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |
FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |